Gladstone Institutional Advisory LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1766530 Bedminster, NJ

Position in REGN

as of Jun 30, 2026 · filed Jul 27, 2026 Compact

Position Value

$238,815

-$57,106 QoQ

Shares Held

383

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#1,002

of 1,328 holders

Holding Since

Jun 2020

11 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Gladstone Institutional Advisory LLC holds $1,952,269 across 9 Biotechnology names. REGN ranks #4 (12.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GPCR	Structure Therapeutics Inc.	13,275	$712,469
2	IBRX	ImmunityBio, Inc.	50,818	$444,911
3	VKTX	Viking Therapeutics, Inc.	9,527	$371,648
4	REGN	Regeneron Pharmaceuticals, Inc. This page	383	$238,815
5	GALT	Galectin Therapeutics Inc	23,900	$110,896
6	AVXL	Anavex Life Sciences Corp.	17,671	$45,767
7	CRDF	Cardiff Oncology, Inc.	13,000	$16,900
8	ATYR	aTYR PHARMA INC	11,300	$6,746

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$238,815	383	0.0%	Shares	Sole	2026-07-27
2026-03-31	$295,921	383	+6.4%	Shares	Sole	2026-05-14
2025-12-31	$277,873	360	-18.4%	Shares	Sole	2026-02-17
2025-09-30	$247,961	441	+5.5%	Shares	Sole	2025-10-22
2025-06-30	$219,450	418	-52.1%	Shares	Sole	2025-08-12
2023-09-30	$718,444	873	-0.5%	Shares	Sole	2023-11-13
2023-06-30	$630,159	877	-10.5%	Shares	Sole	2023-08-10
2022-06-30	$579,307	980	-33.4%	Shares	Sole	2023-01-30
2021-09-30	$890,219	1,471	+177.5%	Shares	Sole	2023-01-30
2020-09-30	$296,683	530	-28.2%	Shares	Sole	2023-01-30
2020-06-30	$460,253	738	—	Shares	Sole	2020-08-17
No filing history on record for this holder in this stock.